|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09906 HONLIV HEALTH
Nominal 
2.100 +0.020 (+0.962%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 415,178 | 12.069% | 760,527 | 727,789 | 606,837 | 524,043 |
| Cost of Sales | (343,557) | 14.322% | (615,683) | (589,394) | (471,531) | (386,451) |
| Gross Profit | 71,621 | 2.389% | 144,844 | 138,395 | 135,306 | 137,592 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (320) | -- | (15,294) | (1,963) | (85) | (4,610) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 28,087 | -12.510% | 51,422 | 63,021 | 50,542 | 30,853 | |
| Taxation | (7,824) | 2.893% | (12,724) | (13,678) | (13,524) | (8,662) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (221) | -6.356% | (388) | (396) | (403) | (351) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 20,042 | -17.397% | 38,310 | 48,947 | 36,615 | 21,840 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 3,746 | 137.089% | 6,023 | (1,460) | 16,019 | 31,117 |
| Depreciation & Amortisation | -- | -- | 60,236 | 54,755 | 33,713 | 28,505 |
| Directors' Emoluments | -- | -- | 3,092 | 3,074 | 2,750 | 1,789 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 4.000 | 0.000% | 7.000 | 8.000 | 6.000 | 4.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.157 | 0.200 | 0.152 | 0.143 |
| NBV per share ($) | 0.936 | -- | 0.903 | 0.916 | 0.936 | 0.875 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 20,042,000 |
| %Change | -17.397% |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.936 |